Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1996;78:1100-1104

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schultz, J. E. J.
Right arrow Articles by Gross, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultz, J. E. J.
Right arrow Articles by Gross, G. J.
(Circulation Research. 1996;78:1100-1104.)
© 1996 American Heart Association, Inc.


Articles

Morphine Mimics the Cardioprotective Effect of Ischemic Preconditioning via a Glibenclamide-Sensitive Mechanism in the Rat Heart

Jo El J. Schultz, Anna K. Hsu, Garrett J. Gross

From the Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee.

Correspondence to Garrett J. Gross, PhD, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226.

Abstract Previous results from our laboratory have suggested that opioid receptors are involved in ischemic preconditioning (PC) in rat heart. Furthermore, other investigators have suggested that µ- and {delta}-opioid receptors mediate analgesia and hypoxic cerebral vasodilatation via opening of ATP-sensitive K+ (KATP) channels. Thus, the purpose of the present study was to test the hypothesis that activation of opioid receptors mimics the cardioprotective effect of ischemic PC and that this effect is produced by activation of KATP channels in the rat heart. Anesthetized open-chest Wistar rats were subjected to six different protocols. All groups were subjected to 30 minutes of occlusion and 2 hours of reperfusion. Ischemic PC was elicited by three 5-minute occlusion periods interspersed with 5 minutes of reperfusion. Similarly, morphine-induced PC was elicited by three 5-minute drug infusions (100 µg/kg IV) interspersed with 5-minute drug-free periods before the prolonged 30-minute occlusion. Infarct size (IS) as a percentage of the area at risk (AAR) was determined by triphenyltetrazolium staining. Ischemic PC and morphine infusions resulted in similar reductions in IS/AAR from 56±5% to 11±3% and 12±5%, respectively (P<.05). Administration of glibenclamide (0.3 mg/kg IV), a KATP channel antagonist, or naloxone (3 mg/kg IV), a nonselective opioid receptor antagonist, both blocked the cardioprotective effects of morphine. These results indicate that opioid receptor stimulation results in a reduction in infarct size similar to that produced by ischemic PC. The effect of morphine is most likely mediated via an opioid receptor-KATP channel–linked mechanism in the rat heart, since glibenclamide abolished its protection.


Key Words: myocardial infarction • ATP-sensitive K+ channels • naloxone • opioid receptors




This article has been cited by other articles:


Home page
IOVSHome page
P. J. Franco, D. C. Fernandez, P. H. Sande, M. I. Keller Sarmiento, M. Chianelli, D. A. Saenz, and R. E. Rosenstein
Effect of Bacterial Lipopolysaccharide on Ischemic Damage in the Rat Retina
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4604 - 4612.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Meco, S. Cirri, C. Gallazzi, G. Magnani, and D. Cosseta
Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study
Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 319 - 325.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
Y. Kadoi
Pharmacological Neuroprotection During Cardiac Surgery
Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 167 - 177.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
T. Steensrud, S. Muller, P. C. Endresen, and D. G. Sorlie
Clinical testing of nicorandil supplemented normokalemic cardioplegic solution
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 521 - 525.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. A. Lessa and E. Tibirica
Pharmacologic Evidence for the Involvement of Central and Peripheral Opioid Receptors in the Cardioprotective Effects of Fentanyl
Anesth. Analg., October 1, 2006; 103(4): 815 - 821.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. M. Tsutsumi, H. H. Patel, D. Huang, and D. M. Roth
Role of 12-lipoxygenase in volatile anesthetic-induced delayed preconditioning in mice
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H979 - H983.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. R. Gross and G. J. Gross
Ligand triggers of classical preconditioning and postconditioning
Cardiovasc Res, May 1, 2006; 70(2): 212 - 221.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. Frassdorf, N. C. Weber, D. Obal, O. Toma, J. Mullenheim, G. Kojda, B. Preckel, and W. Schlack
Morphine Induces Late Cardioprotection in Rat Hearts In Vivo: The Involvement of Opioid Receptors and Nuclear Transcription Factor {kappa}B
Anesth. Analg., October 1, 2005; 101(4): 934 - 941.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Zuurbier, O. Eerbeek, and A. J. Meijer
Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H496 - H499.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X. Jiang, E. Shi, Y. Nakajima, S. Sato, K. Ohno, and H. Yue
Cyclooxygenase-1 Mediates the Final Stage of Morphine-Induced Delayed Cardioprotection in Concert With Cyclooxygenase-2
J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1707 - 1715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Cao, L. Liu, and D. M. Van Winkle
Met5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1955 - H1964.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. A. Rongen, W. J.G. Oyen, B. P. Ramakers, N. P. Riksen, O. C. Boerman, N. Steinmetz, and P. Smits
Annexin A5 Scintigraphy of Forearm as a Novel In Vivo Model of Skeletal Muscle Preconditioning in Humans
Circulation, January 18, 2005; 111(2): 173 - 178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Barrere-Lemaire, N. Combes, C. Sportouch-Dukhan, S. Richard, J. Nargeot, and C. Piot
Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H83 - H88.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaugg, M. C. Schaub, and P. Foex
Myocardial injury and its prevention in the perioperative setting
Br. J. Anaesth., July 1, 2004; 93(1): 21 - 33.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kuzume, R. A. Wolff, K. Amakawa, K. Kuzume, and D. M. Van Winkle
Sustained exogenous administration of Met5-enkephalin protects against infarction in vivo
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2463 - H2470.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaugg, E. Lucchinetti, C. Garcia, T. Pasch, D. R. Spahn, and M. C. Schaub
Anaesthetics and cardiac preconditioning. Part II. Clinical implications
Br. J. Anaesth., October 1, 2003; 91(4): 566 - 576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. B. Elmoselhi, A. Lukas, P. Ostadal, and N. S. Dhalla
Preconditioning attenuates ischemia-reperfusion-induced remodeling of Na+-K+-ATPase in hearts
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1055 - H1063.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. Singh and H. K. Saini
Resident Cardiac Mast Cells and Ischemia-Reperfusion Injury
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 135 - 148.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Coles Jr., D. C. Sigg, and P. A. Iaizzo
Role of kappa -opioid receptor activation in pharmacological preconditioning of swine
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2091 - H2099.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. G. Bovill
Anesthesia for Patients with Impaired Ventricular Function
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 49 - 54.
[PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Shinmura, M. Nagai, K. Tamaki, M. Tani, and R. Bolli
COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2534 - H2543.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Kodani, Y.-T. Xuan, K. Shinmura, H. Takano, X.-L. Tang, and R. Bolli
delta -Opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1943 - H1957.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
R. Kato and P. Foex
Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists: [La protection myocardique contre les lesions d'ischemie-reperfusion par des anesthesiques : une mise a jour pour les anesthesiologistes]
Can J Anesth, October 1, 2002; 49(8): 777 - 791.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
V. Piriou, P. Chiari, F. Lhuillier, O. Bastien, J. Loufoua, O. Raisky, J. S. David, M. Ovize, and J.-J. Lehot
Pharmacological preconditioning: comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium{dagger}
Br. J. Anaesth., September 1, 2002; 89(3): 486 - 491.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. M Fryer, J. A Auchampach, and G. J Gross
Therapeutic receptor targets of ischemic preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 520 - 525.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Wu, Y. Soong, G.-M. Zhao, and H. H. Szeto
A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H783 - H791.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. C. Sigg, J. A. Coles Jr., P. R. Oeltgen, and P. A. Iaizzo
Role of delta -opioid receptor agonists on infarct size reduction in swine
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1953 - H1960.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. B. A. Menown and A. A. J. Adgey
Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals
J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1651 - 1653.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Karck, S. Tanaka, S. F. Bolling, A. Simon, T.-P. Su, P. R. Oeltgen, and A. Haverich
Myocardial protection by ischemic preconditioning and {delta}-opioid receptor activation in the isolated working rat heart
J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 986 - 992.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. C. Sigg, J. A. Coles Jr, W. J. Gallagher, P. R. Oeltgen, and P. A. Iaizzo
Opioid preconditioning: myocardial function and energy metabolism
Ann. Thorac. Surg., November 1, 2001; 72(5): 1576 - 1582.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
C. D. Raeburn, J. C. Cleveland Jr, M. A. Zimmerman, and A. H. Harken
Organ Preconditioning
Arch Surg, November 1, 2001; 136(11): 1263 - 1266.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Schulz, P. Gres, and G. Heusch
Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2175 - H2181.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Fryer, P. F. Pratt, A. K. Hsu, and G. J. Gross
Differential Activation of Extracellular Signal Regulated Kinase Isoforms in Preconditioning and Opioid-Induced Cardioprotection
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 642 - 649.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Fryer, Y. Wang, A. K. Hsu, and G. J. Gross
Essential activation of PKC-{delta} in opioid-initiated cardioprotection
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1346 - H1353.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Krenz, C. P. Baines, X.-M. Yang, G. Heusch, M. V. Cohen, and J. M. Downey
Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 601 - 607.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. T. LEE and C. W. EMALA
Protein Kinase C and Gi/o Proteins Are Involved in Adenosine- and Ischemic Preconditioning--Mediated Renal Protection
J. Am. Soc. Nephrol., February 1, 2001; 12(2): 233 - 240.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Huh, G. J. Gross, H. Nagase, and B. T. Liang
Protection of cardiac myocytes via {delta}1-opioid receptors, protein kinase C, and mitochondrial KATP channels
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H377 - H383.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G.-Y. Wang, S. Wu, J.-M. Pei, X.-C. Yu, and T.-M. Wong
{kappa}- but not {delta}-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H384 - H391.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. P. Bell, M. N. Sack, A. Patel, L. H. Opie, and D. M. Yellon
Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2296 - 2302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Younes, S. Pepe, B. A. Barron, H. A. Spurgeon, E. G. Lakatta, and J. L. Caffrey
Cardiac synthesis, processing, and coronary release of enkephalin-related peptides
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1989 - H1998.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. E. Saltman, I. B. Krukenkamp, G. R. Gaudette, H. Horimoto, and S. Levitsky
Pharmacological preconditioning with the adenosine triphosphate-sensitive potassium channel opener pinacidil
Ann. Thorac. Surg., August 1, 2000; 70(2): 595 - 601.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. R. Gaudette, I. B. Krukenkamp, A. E. Saltman, H. Horimoto, and S. Levitsky
Preconditioning with PKC and the ATP-sensitive potassium channels: a codependent relationship
Ann. Thorac. Surg., August 1, 2000; 70(2): 602 - 608.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Fryer, A. K. Hsu, H. Nagase, and G. J. Gross
Opioid-Induced Cardioprotection against Myocardial Infarction and Arrhythmias: Mitochondrial versus Sarcolemmal ATP-Sensitive Potassium Channels
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 451 - 457.
[Abstract] [Full Text]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
W. E. Johnston
Preconditioning the Brain and Heart: Implications for Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 70 - 79.
[Abstract] [PDF]


Home page
HeartHome page
D M Yellon and G F Baxter
Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?
Heart, April 1, 2000; 83(4): 381 - 387.
[Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. T. Lee and C. W. Emala
Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors
Am J Physiol Renal Physiol, March 1, 2000; 278(3): F380 - F387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Takasaki, R. A. Wolff, G. L. Chien, and D. M. van Winkle
Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta -opioid receptors
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2442 - H2450.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Belhomme, J. Peynet, M. Louzy, J.-M. Launay, M. Kitakaze, and P. Menasche
Evidence for Preconditioning by Isoflurane in Coronary Artery Bypass Graft Surgery
Circulation, November 9, 1999; 100(90002): II-340 - 344.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. E. Benedict, M. B. Benedict, T.-P. Su, and S. F. Bolling
Opiate Drugs and {delta}-Receptor-Mediated Myocardial Protection
Circulation, November 9, 1999; 100(90002): II-357 - 360.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. S. Jahania, J. A. Sanchez, P. Narayan, R. D. Lasley, and R. M. Mentzer Jr
Heart preservation for transplantation: principles and strategies
Ann. Thorac. Surg., November 1, 1999; 68(5): 1983 - 1987.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. P. Perrault and P. Menasche
Preconditioning: can nature’s shield be raised against surgical ischemic-reperfusion injury?
Ann. Thorac. Surg., November 1, 1999; 68(5): 1988 - 1994.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H.-S. V. Chen, S. C. Body, and S. K. Shernan
Myocardial Preconditioning: Characteristics, Mechanisms, and Clinical Applications
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 85 - 97.
[Abstract] [PDF]


Home page
Circ. Res.Home page
B. T. Liang and G. J. Gross
Direct Preconditioning of Cardiac Myocytes via Opioid Receptors and KATP Channels
Circ. Res., June 25, 1999; 84(12): 1396 - 1400.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Kevelaitis, J. Peynet, C. Mouas, J.-M. Launay, and P. Menasche
Opening of Potassium Channels : The Common Cardioprotective Link Between Preconditioning and Natural Hibernation?
Circulation, June 15, 1999; 99(23): 3079 - 3085.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Tomai, F. Crea, A. Gaspardone, F. Versaci, A. S. Ghini, C. Ferri, G. Desideri, L. Chiariello, and P. A. Gioffre
Effects of naloxone on myocardial ischemic preconditioning in humans
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1863 - 1869.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T.-L. Wang, H. Chang, C.-R. Hung, and Y.-Z. Tseng
Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction
Cardiovasc Res, December 1, 1998; 40(3): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. E. J. Schultz, A. K. Hsu, and G. J. Gross
Ischemic Preconditioning in the Intact Rat Heart Is Mediated by {delta}1- But Not µ- or {kappa}-Opioid Receptors
Circulation, April 7, 1998; 97(13): 1282 - 1289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. J. Schultz, A. K. Hsu, H. Nagase, and G. J. Gross
TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels
Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H909 - H914.
[Abstract] [Full Text] [PDF]


Home page